Data science and artificial intelligence (AI) create ground-breaking opportunities for optimizing the drug development process. The processes for finding, creating, testing, and assessing future medications can be significantly accelerated thanks to technology.
Pharma Office at RISE warmly welcomes you to a digital breakfast seminar on Friday, October 7.
The focus will be on small and medium-sized pharmaceutical businesses, and how they can make use of AI to contribute to their pharmaceutical development process.
The advantages and potential of AI for businesses engaged in drug development will be discussed for an hour by Matilda Bäckberg, project manager for the Pharma Office, Erik Ylipää, researcher in AI, and Ian Cotgreave, professor of toxicology and strategist in drug development.